The global Cell Culturemarket was valued at USD 12.41billion in 2016 and is projected to reach USD 30.31billionby 2025, growing at a CAGR of 10.43% from 2017 to 2025.
Cell culture is the process by which cells are grown under controlled conditions, generally outside their natural environment. With increasing advances in biotechnology and its implementation in biopharmaceutical sector, the market is expected to grow at a high CAGR.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growing Awareness on the Benefits Of, and Rising Regulatory Approvals For, Cell Culture-Based Vaccines
1.2 Increase in Demand for Monoclonal Antibodies (MABS)
1.3 Funding for Cell-Based Research
1.4 Growing Preference for Single-Use Technologies
1.5 Technological Advancements
2. Market Restraints
2.1 High Cost of Cell Biology Research
2.2 Lack of Infrastructure for Cell-Based Research in Emerging Economies
Market Segmentation:
1. By Application:
1.1 Cancer Research
1.2 Stem Cell Technologies
1.3 Drug Screening & Development
1.4 Biopharmaceutical/Therapeutic Applications
1.4.1 Vaccine Production
1.4.2 Diagnostics
1.4.3 Recombinant Therapeutic Proteins
1.5 Tissue Engineering & Regenerative Medicine
1.6 Other Applications
2. By End User:
2.1 Pharmaceutical and Biotechnology Companies
2.2 Research Institutes
3. By Product:
3.1 Equipment
3.1.1 Bioreactor
3.1.2 Cell culture vessels
3.1.3 Cell culture storage equipment
3.1.4 Cell culture supporting equipment
3.2 Consumables
3.2.1 Sera
3.2.2 Media
3.2.3 Reagents
3.2.4 Bioreactor Accessories
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific, Inc.
2. Merck KGAA
3. GE Healthcare (A Subsidiary of General Electric Company)
4. Lonza Group AG
5. Corning, Inc.
6. Becton, Dickinson and Company
7. Eppendorf AG
8. Hi-Media Laboratories
9. Sartorius AG
10. Promocell GmbH
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cell Culturemarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL CELL CULTURE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CELL CULTUREMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CELL CULTURE MARKET, BY APPLICATION
5.1 Cancer Research
5.2 Stem Cell Technologies
5.3 Drug Screening & Development
5.4 Biopharmaceutical/Therapeutic Applications
5.4.1 Vaccine Production
5.4.2 Diagnostics
5.4.3 Recombinant Therapeutic Proteins
5.5 Tissue Engineering & Regenerative Medicine
5.6 Other Applications
6 GLOBAL CELL CULTURE MARKET, BY END USER
6.1 Pharmaceutical and Biotechnology Companies
6.2 Research Institutes
7 GLOBAL CELL CULTURE MARKET, BY PRODUCT
7.1 Equipment
7.1.1 Bioreactor
7.1.2 Cell culture vessels
7.1.3 Cell culture storage equipment
7.1.4 Cell culture supporting equipment
7.2 Consumables
7.2.1 Sera
7.2.2 Media
7.2.3 Reagents
7.2.4 Bioreactor Accessories
8 GLOBAL CELL CULTUREMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL CELL CULTUREMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Merck KGAA
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 GE Healthcare (A Subsidiary of General Electric Company)
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Lonza Group AG
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Corning, Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Becton, Dickinson and Company
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Eppendorf AG
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Hi-Media Laboratories
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Sartorius AG
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development
10.10 Promocell GmbH
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development
11 Appendix
11.1 Related Reports